%0 Journal Article
%T Cerebrospinal Fluid Interleukin-10 Biomarker for Vitreoretinal Lymphoma.
%A Zhang X
%A Zhang Y
%A Zhuang Z
%A Zhao C
%A Gao F
%A Dai RP
%A Yu WH
%A Chen YX
%A Zhang W
%A Zhang MF
%J Am J Ophthalmol
%V 246
%N 0
%D 2023 Feb
%M 39110157
%F 5.488
%R 10.1016/j.ajo.2022.10.009
%X OBJECTIVE: To analyze the correlation between cerebrospinal fluid (CSF) interleukin-10 (IL-10) levels and the clinical characteristics in patients with vitreoretinal lymphoma (VRL).
METHODS: Retrospective observational case series.
METHODS: Forty-one patients were diagnosed as VRL and underwent lumbar puncture for CSF examination. Aqueous humor cytokine detection, vitreous cytopathologic analysis, monoclonal gene rearrangement, and flow cytometry were performed. The CSF was assessed through biochemical and cytologic examination, flow cytometry, and cytokine detection.
RESULTS: The median levels of aqueous humor IL-10 and IL-6 were 415.0 and 40.7 pg/mL. The median CSF levels of IL-10 and IL-6 were 35.7 and 3.5 pg/mL, respectively. IL-10 levels in CSF were higher than normal in 37 patients (90.2%) and higher in patients with intracranial lesions. The level of CSF IL-10 decreased after systemic treatment, and it rose before intracranial lesion onset or recurrence. The level of IL-10 in CSF was related to the duration of ocular symptoms, but was not related to the level of IL-10 in aqueous humor. There was no significant difference in CSF IL-10 levels between patients with and without anterior chamber inflammation or retinal lesions. In eyes with recurrent vitreoretinal lymphoma, the level of IL-10 in aqueous humor increased significantly, but there was no corresponding increase in the level of IL-10 in CSF.
CONCLUSIONS: CSF IL-10 is a potentially important biomarker in VRL, especially in the monitoring of intracranial lesions.